| Literature DB >> 34940707 |
Qiqi Gao1, Byoung-Soo Kim2, Ge Gao1,3.
Abstract
Alginate is a natural polysaccharide that typically originates from various species of algae. Due to its low cost, good biocompatibility, and rapid ionic gelation, the alginate hydrogel has become a good option of bioink source for 3D bioprinting. However, the lack of cell adhesive moieties, erratic biodegradability, and poor printability are the critical limitations of alginate hydrogel bioink. This review discusses the pivotal properties of alginate hydrogel as a bioink for 3D bioprinting technologies. Afterward, a variety of advanced material formulations and biofabrication strategies that have recently been developed to overcome the drawbacks of alginate hydrogel bioink will be focused on. In addition, the applications of these advanced solutions for 3D bioprinting of tissue/organ mimicries such as regenerative implants and in vitro tissue models using alginate-based bioink will be systematically summarized.Entities:
Keywords: 3D bioprinting strategy; alginate hydrogel; bioink formulation; biomedical applications
Mesh:
Substances:
Year: 2021 PMID: 34940707 PMCID: PMC8708555 DOI: 10.3390/md19120708
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1Schematic illustration representing advanced strategies for improving the performances of alginate bioinks, as well as their applications in 3D bioprinting of regenerative implants and in vitro tissue models. This figure was prepared using a template on the Sevier medical art website (http://www.sevier.fr/sevier-medical-art, accessed on 25 November 2021).
Figure 2Schematic illustration showing the working principles of prevalent 3D bioprinting techniques. (A) inkjet-based 3D bioprinting, (B) extrusion-based 3D bioprinting, (C) (i) laser-assisted jetting, and (ii) stereolithography.
Figure 3Representative examples that show advanced bioprinting strategies for the adoption of alginate bioinks. (A) A schematic of alginate bioink 3D bioprinting assisted by an aerosol-sparing process, producing semi-crosslinked struts (orange: non-crosslinked, purple: crosslinked by exposure to CaCl2 aerosol). Reproduced with permission from [119]. (B) (i) A schematic depicting the fabrication of ionic/covalent dual-crosslinkable OMA beads; and (ii) the 3D bioprinting of femur, skull, and ear models using the hMSCs-laden OMA microgel bioinks (scale: femur, 1 cm; skull and ear, 100 μm). Reproduced with permission from [122]. (C) (i) A schematic of 3D bioprinting of cells within the alginate microgel supporting medium, where the OMA microgels fluidize when stress is applied by the motion of the printing nozzles (shear-thinning region) and rapidly fill in after the needle passes (self-healing region) while the supporting medium without shear presents solid-like properties; and (ii) captures of bioprinting a letter “C” (time-course images), a cubic, an acronym “CWRU”, and a femur using stem cell-only bioinks. Reproduced with permission from [123]. (D) (i) A schematic of the fabrication process of cell-laden PCL/alginate hybrid scaffold using the collaborative 3D bioprinting strategy, and (ii) the SEM images of the fabricated porous hybrid scaffold at magnifications of ×25, ×75, and ×150. Reproduced with permission from [124]. (E) Schematic illustration of the fabrication process that coaxial extrudes a GelMA/alginate hybrid bioin through the core needle and CaCl2 solution through the shell needle, which sequentially undergoes ionic crosslinking and covalent crosslinking, resulting in direct 3D bioprinting of GelMA/alginate fibers. Reproduced with permission from [126]. (F) (i) A schematic of coaxial printing CaCl2/alginate solutions using a core/shell nozzle; and (ii) an image of bioprinted alginate microfluidic channels. Reproduced with permission from [128]. (G) (i) A schematic of the formulated cell-laden alginate/PEO/fibrin bioink for the electrohydrodynamic-direct-writing fabrication, (ii) A schematic and SEM images of microfibers fabricated using 50 mm/s nozzle moving speed (scale of the inset: 100 μm), (iii) A schematic showing the micro-scale printing of C2C12 cell-laden constructs and immunofluorescent images revealing the orientation of matured muscular fibers. Reproduced with permission from [129]. (H) A schematic of 4D bioprinting for fabricate Alg/MC hydrogels and their 3D deformations in CaCl2 solution. Reproduced with permission from [130].
Representative cases of 3D bioprinting regenerative implants using alginate-based bioinks.
| Tissue | Bioink | Cell Type | Strategy | Achievement | Ref. |
|---|---|---|---|---|---|
|
| Nanocellulose-alginate bioink | Human nasoseptal chondrocytes | Physical combination | Constructs with high fidelity and stability | [ |
| hyaluronic acid/alginate bioink, PCL as a scaffold | Human articular chondrocytes | Physical combination | Improved printability, gelling abilities, stiffness and degradability | [ | |
| Alginate Sulfate–Nanocellulose Bioinks | Bovine chondrocytes | Chemical modification | High shape fidelity, good printability | [ | |
| Nanocellulose/Alginate Bioink | iPSCs | Physical combination | Bioprinted iPSCs for cartilage regeneration | [ | |
| Collagen-alginate bioink | Rat chondrocytes | Physical combination | Improved mechanical strength, enhanced cells adhesion, proliferation | [ | |
| Polylactic Acid (PLA) Nanofiber−Alginate Hydrogel Bioink | Human adipose-derived stem cells | Physical combination | Improved hASC metabolic activity and proliferation | [ | |
| Alginate, gelatin, and fibrinogen as bioink | hMSCs | Physical combination | The addition of TGF-β1 and BMP-2 promoted cells differentiation | [ | |
| Alginate and short sub-micron polylactide (PLA) fibers | Human chondrocytes | Physical combination | High cell viability | [ | |
|
| alginate-sulfate bioink | MC3T3-E1 osteoblasts | Chemical modification | Improved osteoblastic proliferation and differentiation | [ |
| Graphene oxide/alginate bioink | hMSCs | Physical combination | Enhanced osteogenic differentiation, improved printability | [ | |
| Alginate CaCl2 bioink | Human bone marrow-derived MSCs | Chemical modification | Increased osteogenic differentiation | [ | |
| RGD-γ-irradiated alginate and nano-hydroxyapatite (nHA) complexed to plasmid DNA | Human bone marrow-derived MSCs | Chemical modification | Superior levels of vascularization and mineralization | [ | |
|
| Sodium alginate | L929 mouse fibroblasts | Collaborative 3D bioprinting | Multilevel fluidic channels | [ |
| Sodium alginate, collagen | HUVECs | Microgel-bioink-based 3D bioprinting | Achieved rapid and | [ | |
| VdECM/alginate bioink | HUVEC/HAoSMCs | Collaborative 3D bioprinting | As transplants in vivo for three weeks | [ | |
| gelatin-based alginate/carbon nanotubes blend bioink | Fibroblasts | Physical combination | Enhanced mechanical properties | [ | |
| Gelatin-methacryloyl (GelMA) + PEGDA + alginate lyase | Vascular smooth muscle cells/vascular endothelial cells | Collaborative 3D bioprinting & Physical combination | Two-cell-layered structure | [ | |
|
| Gelatin and sodium alginate hydrogel, fibroblast cells | Fibroblasts | Physical combination | Situ 3D bioprinting | [ |
| Sodium alginate, sodium carboxymethyl cellulose | / | Physical combination | Repaired rabbit wound defeat | [ | |
|
| Sodium alginate, gelatin | Rat Schwann cells | Physical combination | Improved cell adhesion and related factor expression, in vivo | [ |
|
| Gelatin | Mouse C2C12 myoblast cells | Collaborative 3D bioprinting | Dually crosslinking can provide the optimal niche for muscle tissue formation | [ |
| PEG-Fibrinogen (PF)/alginate | Human C2C12 myoblast cells | Collaborative 3D bioprinting | Formed multinucleated myotubes | [ |